Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Human papillomavirus self-sampling for screening non-attenders: Opt-in pilot implementation with electronic communication platforms

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tibolone and risk of gynecological hormone sensitive cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Does HPV status influence survival after vulvar cancer?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence, type distribution, and risk factors for oral HPV in Danish renal transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

In organized cervical screening programs, typically 25% of the invited women do not attend. The Copenhagen Self-sampling Initiative (CSi) aimed to gain experiences on participation among screening non-attenders in the Capital Region of Denmark. Here, we report on the effectiveness of different communication platforms used in the pilot with suggestions for strategies prior to a full-implementation. Moreover, an innovative approach using self-sampling brushes with unique radio frequency identification chips allowed for unprecedented levels patient identification safety. Non-attenders from the Capital Region of Denmark were identified via the organized national invitation module. Screening history was obtained via the nationwide pathology registry. 24,000 women were invited, and as an alternative to the regular communication platforms (letter and phone), women could request a home test via a mobile-friendly webpage. Instruction material and video-animation in several languages were made available online. Chi-square test was used to test differences. Out of all invited, 31.7% requested a home test, and 20.4% returned it to the laboratory. In addition, 9.7% were screened at the physician after receiving the invitation. Stratified by screening history, long-term unscreened women were less likely to participate than intermittently screened women (28% vs 16%, p<0.001). Of all contacts received, 63.7% (62.7-64.6) came via letter, and 31.2% (30.2-32.2) via webpage/mobile-app. Self-sampling was well-accepted among non-attenders. Adopting modern technology-based platforms into the current organized screening program would serve as a convenient communication method between health authority and citizens, allowing easy access for the citizen and reducing the work load in administrating self-sampling approaches. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftRadiation Oncology Investigations
Vol/bind140
Udgave nummer10
Sider (fra-til)2212-2219
ISSN0020-7136
DOI
StatusUdgivet - 1 maj 2017

ID: 49878502